Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassay
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassay
Authors
Keywords
Inflammatory bowel disease, Oncostatin M, Disease activity, Infliximab, Chemiluminescence immunoassay
Journal
CLINICAL BIOCHEMISTRY
Volume 100, Issue -, Pages 35-41
Publisher
Elsevier BV
Online
2021-11-26
DOI
10.1016/j.clinbiochem.2021.11.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
- (2021) Sare Verstockt et al. INFLAMMATORY BOWEL DISEASES
- Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort
- (2021) Jennifer Ezirike Ladipo et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease
- (2020) Francisco Guilherme Cancela e Penna et al. BMC GASTROENTEROLOGY
- Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease
- (2020) Lung-Yi Mak et al. Clinical and Translational Gastroenterology
- Plasma Oncostatin-M, TNF-α, IL-7 and IL-13 network predicts Crohn’s disease response to Infliximab, as assessed by calprotectin log-drop.
- (2020) Beatriz Mateos et al. DIGESTIVE DISEASES
- Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab
- (2020) Lorenzo Bertani et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease
- (2019) Bram Verstockt et al. EBioMedicine
- Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease
- (2019) Steffen Bank et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Roseburia intestinalis inhibits oncostatin M and maintains tight junction integrity in a murine model of acute experimental colitis
- (2019) Bei Tan et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines
- (2019) Nathaniel R. West Frontiers in Immunology
- Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)
- (2019) Sare Verstockt et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis
- (2018) Alissa Walsh et al. Journal of Crohns & Colitis
- Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
- (2017) Nathaniel R West et al. NATURE MEDICINE
- Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease
- (2016) Paul Lochhead et al. Clinical Gastroenterology and Hepatology
- Fecal calprotectin concentration is increased in children with celiac disease: relation with histopathological findings
- (2016) Necati BALAMTEKIN et al. Turkish Journal of Gastroenterology
- High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis
- (2015) Margalida Calafat et al. INFLAMMATORY BOWEL DISEASES
- Tailoring anti-TNF therapy in IBD: drug levels and disease activity
- (2014) Shomron Ben-Horin et al. Nature Reviews Gastroenterology & Hepatology
- Oncostatin M Mediates STAT3-Dependent Intestinal Epithelial Restitution via Increased Cell Proliferation, Decreased Apoptosis and Upregulation of SERPIN Family Members
- (2014) Florian Beigel et al. PLoS One
- European evidence based consensus for endoscopy in inflammatory bowel disease
- (2013) Vito Annese et al. Journal of Crohns & Colitis
- Prospective Multicenter Study Evaluating Fecal Calprotectin in Adult Acute Bacterial Diarrhea
- (2008) Yogesh M. Shastri et al. AMERICAN JOURNAL OF MEDICINE
- Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
- (2008) R. Berni Canani et al. DIGESTIVE AND LIVER DISEASE
- Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease
- (2007) Rebecca Carey et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now